The improved performance follows a 17.2% increase in its revenue to $42.8 million in FY2020, thanks to higher income from its pharmaceutical services segment which benefitted from hospitals’ stock piling of medical supplies to meet demand and in preparation of supply chain disruptions.
Earnings of Alliance Healthcare surged 635.1% to $2.3 million in FY2020 ended June 30, from the $0.3 million posted a year ago. The latest full-year results is a first for the company which went public at 20 cents a share on May 31 2019.
On a fully diluted basis, this translates to earnings per share of 1.12 cents in FY2020 compared to 0.15 cents in the previous year end.
